Teilo H Schaller

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Squamous Cell Carcinoma

Mass Spectrometry

Top Venues

Cancer research

Journal of proteome research

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Shawn M Sweeney, Hisham K Hamadeh, Natalie D Abrams, Stacey J Adam, Sara Brenner, Dana E Connors, Gerard J Davis, Louis D Fiore, Susan H Gawel, Robert L Grossman, Sean E Hanlon, Karl Hsu, Gary J Kelloff, Ilan R Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S Miller, Emily Morgan, Lata Mukundan, Thomas O'Brien, Paul B Robbins, Eric H Rubin, Liz Salmi, Teilo H Schaller, George Shi, Caroline C Sigman, Sudhir Srivastava
Case studies for overcoming challenges in using big data in cancer. Cancer research (2023)
Shawn M Sweeney, Hisham K Hamadeh, Natalie D Abrams, Stacey J Adam, Sara Brenner, Dana E Connors, Gerard J Davis, Louis D Fiore, Susan H Gawel, Robert L Grossman, Sean E Hanlon, Karl Hsu, Gary J Kelloff, Ilan R Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S Miller, Emily Morgan, Lata Mukundan, Thomas O'Brien, Paul B Robbins, Eric H Rubin, Liz Salmi, Teilo H Schaller, George Shi, Caroline C Sigman, Sudhir Srivastava
Challenges to using big data in cancer. Cancer research (2023)
Teilo H Schaller, David J Snyder, Ivan Spasojevic, Patrick C Gedeon, Luis Sanchez-Perez, John H Sampson
First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach. Journal for immunotherapy of cancer 8 (1) (2021)
Patrick C Gedeon, Michael A Streicker, Teilo H Schaller, Gary E Archer, Micheal P Jokinen, John H Sampson
GLP toxicology study of a fully-human T cell redirecting CD3:EGFRvIII binding immunotherapeutic bispecific antibody. PloS one 15 (7) (2020)
Teilo H Schaller, Matthew W Foster, J Will Thompson, Ivan Spasojevic, Deimante Normantaite, M Arthur Moseley, Luis Sanchez-Perez, John H Sampson
Pharmacokinetic Analysis of a Novel Human EGFRvIII:CD3 Bispecific Antibody in Plasma and Whole Blood Using a High-Resolution Targeted Mass Spectrometry Approach. Journal of proteome research 18 (8) (2019)